Roche: Enters Licensing Agreement Worth Up To $1.16B With Rona Therapeutics For Investigational Obesity Drug Candidate

Rona To Receive $100M Upfront Payment - Rona Eligible For Up To $1.06B In Potential Milestone Payments Plus Tiered Royalties On Global Net Sales - Candidate Is Investigational RNAi Targeting ALK7